ENDRA Life Sciences Investor Relations Material

ENDRA Life Sciences Inc. is a medical technology company focused on developing advanced ultrasound technologies for clinical use. Its main product, the Thermo-Acoustic Enhanced Ultrasound (TAEUS) platform, is designed to provide imaging capabilities similar to MRI, but at a fraction of the cost and at the point of care. ENDRA’s technology is primarily aimed at improving the diagnosis and monitoring of liver disease, particularly non-alcoholic fatty liver disease (NAFLD), with potential applications in other conditions. The company is headquartered in Ann Arbor, Michigan, USA, and its shares are listed on the NASDAQ.